Acute and chronic pretreatment with essential oil of peppermint (Mentha × piperita L., Lamiaceae) influences drug effects

Phytotherapy Research

Volumn 26, Issue 6, 2012, Pages 820-825

  Samojlik, Isidora ^a   Petković, Stojan ^b   Mimica Dukić, Neda ^c   Božin, Biljana ^a  

^a UNIVERSITY OF NOVI SAD   (Serbia)

^b Clinical Centre of Vojvodina   (Serbia)

^c UNIVERSITY OF NOVI SAD   (Serbia)

Author keywords

codeine; drug herb interactions; midazolam; pentobarbital; peppermint oil

Indexed keywords

CODEINE; LOPERAMIDE; MIDAZOLAM; PENTOBARBITAL; PEPPERMINT OIL;

ACUTE DRUG ADMINISTRATION; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG DETERMINATION; DRUG EFFECT; INTESTINE MOTILITY; MALE; MOTOR COORDINATION; MOUSE; NONHUMAN; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SLEEP TIME;

ADMINISTRATION, ORAL; ANALGESICS; ANIMALS; CODEINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; EMULSIONS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HERB-DRUG INTERACTIONS; MALE; MENTHA PIPERITA; MICE; MIDAZOLAM; OILS, VOLATILE; PENTOBARBITAL; PLANT LEAVES; PLANT OILS; SLEEP; TIME FACTORS;

LAMIACEAE; MENTHA; MENTHA X PIPERITA; MUS;

EID: 84861802652     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3638     Document Type: Article

References (29)

1. Adams RP,. (ed). 1995. Identification of Essential Oil Components by Gas Chromatography-Mass Spectroscopy. Allured Publishing Corp.: Carol Steam, IL.
2. Blumenthal M, Busse WR, Goldberg A, et al. (eds). 1998. The Complete German Commission E Monographs-Therapeutic Guide to Herbal Medicines. American Botanical Council: Austin, TX.
3. Colalto C,. 2010. Herbal interactions on absorption of drugs: Mechanisms of action and clinical risk assessment. Pharmacol Res 62: 207-227.
4. De Smet PAGM,. 2004. Health risks of herbal remedies: An update. Clin Pharmacol Ther 76: 1-17.
5. Dresser GK, Wacher V, Wong S, Wong HT, Bailey DG,. 2002. Evaluation of peppermint oil and ascorbyl palmitate as inhibitors of cytochrome P4503A4 activity in vitro and in vivo. Clin Pharmacol Ther 72: 247-255.
6. European Pharmacopeia. 2002. 4th edition. Council of Europe: Strasbourg.
7. Gelal A, Balkan D, Ozzeybek D, et al., 2005. Effect of menthol on the pharmacokinetics and pharmacodynamics of felodipine in healthy subjects. Eur J Clin Pharmacol 60: 785-790.
8. Hammer KA, Carson CF, Riley TV,. 1999. Antimicrobial activity of essential oils and other plant extracts. J Appl Microbiol 86: 985-990.
9. Hellum BH, Nilsen OG,. 2008. In vitro inhibition of CYP3A4 metabolism and p-glycoprotein-mediated transport by trade herbal products. Basic Clin Pharmacol Toxicol 102: 466-475.
10. Hu Z, Yang X, Ho PCL, et al., 2005. Herb-drug interactions: a literature review. Drugs 65: 1239-1282.
11. Izzo AA, Ernst E,. 2009. Interactions between herbal medicines and prescribed drugs: an updated systematic review. Drugs 69: 1777-1798.
12. Johne A, Roots I,. 2005. Clinical drug interactions with medicinal herbs. Evid Based Integrative Med 2: 207-228.
13. Lurcott G,. 1999. The effects of the genetic absence and inhibition of CYP2D6 on the metabolism of codeine and its derivatives, hydrocodone and oxycodone. Anesth Prog 45: 154-156.
14. Madyastha KM, Srivatsan V,. 1988. Studies on the metabolism of l-menthol in rats. Drug Metab Disposit 16: 765-772.
15. McKay DL, Blumberg JB,. 2006. A review of the bioactivity and potential health benefits of peppermint tea (Mentha piperita L.). Phytother Res 20: 619-633.
16. Mimica-Dukic N, Bozin B, Sokovic M, Mihajlovic B, Matavulj M,. 2003. Antimicrobial and antioxidant activities of three Mentha species essential oils. Planta Med 69: 413-419.
17. Mimica-Dukic N, Husain SZ, Jancic R, Gasic O, Loukis A, Khan MB,. 1991. Composition and variation of essential oil constituents in three Mentha L. (Labiatae) species in Yugoslavia. Pak J Bot 23: 243-248.
18. Nair B,. 2001. Final report on the safety assessment of Mentha piperita (peppermint) oil, Mentha piperita (peppermint) leaf extract, Mentha piperita (peppermint) leaf, Mentha piperita (peppermint) leaf water. Int J Toxicol 20: 61-73.
19. Pal D, Mitra AK,. 2006. MDR- and CYP3A4-mediated drug-herbal interactions. Life Sci 78: 2131-2145.
20. Perloff MD, Von Moltke LL, Greenblatt DJ,. 2003. Differential metabolism of midazolam in mouse liver and intestine microsomes: a comparison of cytochrome P450 activity and expression. Xenobiotica 33: 365-377.
21. Schelz Z, Molnar J, Hohmann J,. 2006. Antimicrobial and antiplasmid activities of essential oils. Fitoterapia 77: 279-285.
22. Shord SS, Shah K, Lukose A,. 2009. Drug-botanical interactions: A review of the laboratory, animal, and human data for 8 common botanicals. Integr Cancer Ther 8: 208-227.
23. Tarirai C, Viljoen AM, Hamman JH,. 2010. Herb-drug pharmacokinetic interactions reviewed. Expert Opin Drug Metab Toxicol 6: 1515-1538.
24. Tsuji R, Isobe N, Kurita Y, Hanai K, Yabusaki Y, Kawasaki H,. 1996. Species difference in the inhibition of pentobarbital metabolism by empenthrin. Environ Toxicol Pharmacol 2: 331-337.
25. Umezu T, Morita M,. 2003. Evidence for the involvement of dopamine in ambulation promoted by menthol in mice. J Pharmacol Sci 91: 125-135.
26. Vogel GH, Vogel WH,. (eds). 2002. Drug Discovery and Evaluation: Pharmacological Assays, 2nd edn. Springer-Verlag: Berlin.
27. Wacher VJ, Wong S, Wong HT,. 2002. Peppermint oil enhances cyclosporine oral bioavailability in rats: comparison with d-α-tocopheryl poly(ethylene glycol 1000)succinate (TPGS) and ketoconazole. J Pharm Sci 91: 77-90.
28. WHO. 2002. WHO Monographs on Selected Medicinal Plants, Vol. 2. World Health Organization: Geneva.
29. Zhou S, Lim LY, Chowbay B,. 2004. Herbal modulation of P-glycoprotein. Drug Metab Rev 36: 57-104.